Dr. Matthew Reynolds on Quality of Life From AF Ablation vs. Antiarrhythmic Drugs — Video
Posted Mar 21 2011 9:00am
In this video, Dr. Matthew Reynolds, of the Harvard Clinical Research Institute, discussed his quality of life findings from use of catheter ablation and antiarrhythmic drugs for treatment of atrial fibrillation. He analyzed quality of life data that was collected as part of the THERMOCOOL catheter trial in which catheter ablation was found to be significantly more effective at maintaining sinus rhythm than antiarrhythmic drugs.
Dr. Reynolds looked at the quality of life data collected in the trial and found that there were dramatic and meaningful differences. Two factors emerged as being correlated with improved quality of lifehaving had an ablation and absence of recurrent symptomatic AF. The study indicated that after failing one antiarrhythmic drug you have a much better chance of improvement in symptoms and improved quality of life from having an ablation than from trying more drugs.